Skip to main content
. 2020 Aug 26;12(9):2417. doi: 10.3390/cancers12092417

Figure 2.

Figure 2

Expression of TIM-3 on NK cells in response to cancer cells (mean ± SEM). Percentage (left panels) and MFI (right panels) of TIM-3 on human peripheral blood NK cells in response to (A,B) Prostate cancer (PC3) (n = 3 donors) and (C,D) primary human glioblastoma (GBM43) cells (n = 3) after 4-h co-culture at E:T ratios of 2.5:1 and 10:1.* p < 0.05, ** p < 0.01, *** p < 0.001.